Evidence map›Paper›PMID 42422878›Full record

ArticleFrontiers in molecular biosciences2026

Haiying Sun, Chao Ma, Wei Jia, Mei Xue, Mengqiao Zhang, Junfang Shuai, Jing Wang, Fanyue Sun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Haiying SunDepartment of Gastroenterology, Affiliated Beijing Rehabilitation Hospital of Capital Medical University, Beijing, China.
Chao MaDepartment of Gastroenterology, Affiliated Beijing Rehabilitation Hospital of Capital Medical University, Beijing, China.
Wei JiaDepartment of Gastroenterology, Affiliated Beijing Rehabilitation Hospital of Capital Medical University, Beijing, China.
Mei XueDepartment of Gastroenterology, Affiliated Beijing Rehabilitation Hospital of Capital Medical University, Beijing, China.
Mengqiao ZhangDepartment of Gastroenterology, Affiliated Beijing Rehabilitation Hospital of Capital Medical University, Beijing, China.
Junfang ShuaiDepartment of Gastroenterology, Affiliated Beijing Rehabilitation Hospital of Capital Medical University, Beijing, China.
Jing WangDepartment of Gastroenterology, Affiliated Beijing Rehabilitation Hospital of Capital Medical University, Beijing, China.
Fanyue SunDepartment of Gastroenterology, Affiliated Beijing Rehabilitation Hospital of Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Colon adenocarcinoma (COAD) shows marked clinical heterogeneity, and robust biomarkers with mechanistic relevance are still needed for prognostic stratification. Methods: We performed integrated analyses of The Cancer Genome Atlas pan-cancer and COAD cohorts, followed by external validation in GEO datasets. Prognostic associations were evaluated by Cox and Kaplan-Meier analyses, and clinicopathological relevance was assessed in TCGA-COAD. A prognostic nomogram combining Results: Conclusion:

Indexed as

colon adenocarcinomaferroptosisprognostic biomarkerRBMS3tumor microenvironment

Identifiers

PMID42422878
PMCPMC13341479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.